Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The RENEW Study: (Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds): A Non-Inferiority Study

NCT05607979 is registered in ClinicalTrials.gov with Lavior Pharma Inc. as lead sponsor.

NCT NCT05607979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05607979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The RENEW Study: (Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds): A Non-Inferiority Study
Lead sponsor
Lavior Pharma Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
December 15, 2022
Completion date
May 1, 2024
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer